Skip to the page

Data / Form D filings / Pluri Inc.

Pluri Inc.: Form D filings

Pluri Inc., a biotechnology company in Haifa, Israel, filed 5 Form D notices with the SEC between 2010 and 2026. The latest, on September 4, 2026, reports $3.7 million sold of a $3.7 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5, Haifa, Israel, 35084
Phone
972-74-710-8600
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Nevada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1158780

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 4, 2026New notice$3,677,751$3,677,7511Aug 28, 2026sec.gov
Mar 19, 2025New notice$3,500,000$3,500,0001Feb 3, 2025sec.gov
Dec 30, 2022New notice$8,469,323$8,469,32314Dec 13, 2022sec.gov
Oct 14, 2010New notice$1,220,003$1,220,0039Oct 12, 2010sec.gov
May 11, 2010New notice$250,000$250,0001Apr 26, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Yaky YanayExecutive Officer, DirectorChief Executive Officer, President and Director
Liat ZaltsExecutive OfficerChief Financial Officer and Treasurer
Doron ShorrerDirector
Rami LeviDirector
Maital Shemesh-RasmussenDirector
Alexandre WeinsteinDirectorChairman of the Board of Directors

Every Form D from the week of Aug 31, 2026 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Pluri Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.